"Top US regulators met with Bayer’s CEO last year to discuss “litigation” issues – including “Supreme Court Action” over its glyphosate weed killer – just months before the Trump administration took a series of steps to boost Bayer’s case at the high court, internal government records show.
The June 17 meeting, between officials at the Environmental Protection Agency (EPA) and Bayer CEO Bill Anderson and two other top Bayer executives, came as Germany-based Bayer was working to quash costly US litigation brought by tens of thousands of people who allege they developed cancer from their use of the company’s glyphosate-based herbicides, such as Roundup.
At the core of those lawsuits are claims that the company failed to warn users of the risk of cancer, as shown in several research studies over many years.
One of Bayer’s stated key strategies to try to end the litigation, which has so far cost Bayer billions of dollars in settlements and jury verdict awards, is getting the Supreme Court to agree with Bayer’s argument that if the EPA does not require a cancer warning on its glyphosate products, the company cannot be held liable for failing to warn of a cancer risk."
Carey Gillam reports for The New Lede March 11, 2026.
SEE ALSO:
"Bayer’s All-Out Campaign to Protect Roundup" (Circle of Blue)
